NNNathan D. Nuzum

Nathan D. Nuzum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathan D. Nuzum has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Wei-Peng Teo

    Physical Education and Sports Science Academic Group, National Institute of Education, Nanyang Technological University, Singapore, Singapore

    5 shared publications
  • Ashlee M. Hendy

    Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences Deakin University Geelong Victoria Australia

    4 shared publications
  • Helen Macpherson

    Deakin University, Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Geelong, Australia

    4 shared publications
  • Wei-Peng Teo

    Physical Education and Sports Science Academic Group, National Institute of Education, Nanyang Technological University, Singapore

    4 shared publications
  • Amy Loughman

    Deakin University, Food & Mood Centre, IMPACT Strategic Research Centre, School of Medicine, Geelong, Australia

    3 shared publications
  • Ewa A. Szymlek-Gay

    Deakin University, Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Geelong, Australia

    3 shared publications

Latest Publications

  • Open Access

    More than just a number: the gut microbiota and brain function across the extremes of life

    by Nathan D. Nuzum, Clara Deady, Sarah Kittel-Schneider, John F. Cryan, Siobhain M. O'MAhony, Gerard Clarke

    Understanding the interrelationship between the gut microbiota and host physiology, although still in its relative infancy, has taken important steps forward over the past decade. In the context of brain disorders including those characterized by neurodevelopmental and neurodegenerative changes there have been important advances. However, initially research involved correlational analyses, had limited translational scope, and lacked functional assessments. Thus, largescale longitudinal clinical investigations that assess causation and underlying mechanisms via in depth analysis methods are needed. In neurodegeneration research, strong causal evidence now links the gut microbiome to Alzheimer's (AD), and Parkinson's Disease (PD), as supported by human-to-animal transplantation studies. Longitudinal interventions are being conducted in AD, PD, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis. Neurodevelopmental research has also seen a boon in microbiome-related clinical research including in autism, Attention-deficit/hyperactivity disorder, and schizophrenia, which is confirming prior animal model work regarding the key time-windows in the gut microbiome important for infant cognition. While recent research advances represent important progress, fundamental knowledge gaps and obstacles remain. Knowing how and why the gut microbiome changes at the extremes of life will develop our mechanistic understanding and help build the evidence base as we strive toward counteracting microbial missteps with precision therapeutic interventions.


  • Differences in the gut microbiome across typical ageing and in Parkinson's disease

    by Nathan D. Nuzum, Ewa A. Szymlek-Gay, Stella Loke, Samantha L. Dawson, Wei-Peng Teo, Ashlee M. Hendy, Amy Loughman, Helen Macpherson


  • Open Access

    A Review of the Measurement of the Neurology of Gait in Cognitive Dysfunction or Dementia, Focusing on the Application of fNIRS during Dual-Task Gait Assessment

    by Sophia X. Sui, Ashlee M. Hendy, Wei-Peng Teo, Joshua T. Moran, Nathan D. Nuzum, Julie A. Pasco

    Poor motor function or physical performance is a predictor of cognitive decline. Additionally, slow gait speed is associated with poor cognitive performance, with gait disturbances being a risk factor for dementia. Parallel declines in muscular and cognitive performance (resulting in cognitive frailty) might be driven primarily by muscle deterioration, but bidirectional pathways involving muscle–brain crosstalk through the central and peripheral nervous systems are likely to exist. Following screening, early-stage parallel declines may be manageable and modifiable through simple interventions. Gait–brain relationships in dementia and the underlying mechanisms are not fully understood; therefore, the current authors critically reviewed the literature on the gait–brain relationship and the underlying mechanisms and the feasibility/accuracy of assessment tools in order to identify research gaps. The authors suggest that dual-task gait is involved in concurrent cognitive and motor activities, reflecting how the brain allocates resources when gait is challenged by an additional task and that poor performance on dual-task gait is a predictor of dementia onset. Thus, tools or protocols that allow the identification of subtle disease- or disorder-related changes in gait are highly desirable to improve diagnosis. Functional near-infrared spectroscopy (fNIRS) is a non-invasive, cost-effective, safe, simple, portable, and non-motion-sensitive neuroimaging technique, widely used in studies of clinical populations such as people suffering from Alzheimer’s disease, depression, and other chronic neurological disorders. If fNIRS can help researchers to better understand gait disturbance, then fNIRS could form the basis of a cost-effective means of identifying people at risk of cognitive dysfunction and dementia. The major research gap identified in this review relates to the role of the central/peripheral nervous system when performing dual tasks.


  • Open Access

    To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson’s Disease

    by Nathan D. Nuzum, Amy Loughman, Ewa A. Szymlek-Gay, Wei-Peng Teo, Ashlee M. Hendy, Helen Macpherson

    There is continued debate regarding Parkinson’s disease etiology and whether it originates in the brain or begins in the gut. Recently, evidence has been provided for both, with Parkinson’s disease onset presenting as either a “body-first” or “brain-first” progression. Most research indicates those with Parkinson’s disease have an altered gut microbiome compared to controls. However, some studies do not report gut microbiome differences, potentially due to the brain or body-first progression type. Based on the etiology of each proposed progression, individuals with the body-first progression may exhibit altered gut microbiomes, i.e., where short-chain fatty acid producing bacteria are reduced, while the brain-first progression may not. Future microbiome research should consider this hypothesis and investigate whether gut microbiome differences exist between each type of progression. This may further elucidate the impact of the gut microbiome in Parkinson’s disease and show how it may not be homogenous across individuals with Parkinson’s disease.


  • Inhibition, excitation and bilateral transfer following a unilateral complex finger‐tapping task in young and older adults

    by Nathan D. Nuzum, Wei‐Peng Teo, Helen Macpherson, Amy Loughman, Ewa A. Szymlek‐Gay, Ashlee Hendy

    Neuroplasticity underpins motor learning, with abnormal neuroplasticity related to age‐associated motor declines. Bilateral transfer of motor learning, through rehabilitation, may mitigate these declines; however, the magnitude of transfer may be reduced in older populations. This study investigated excitatory and inhibitory pathways in the trained and untrained hemispheres following unilateral training of a complex finger‐tapping task across ageing. Fifteen young (26.2 ± 3.8 years) and 11 older adults (63.7 ± 15.4 years) received transcranial magnetic stimulation, although surface electromyography was recorded from the extensor digitorum communis (EDC) and abductor pollicis brevis (APB), before and after practicing a complex finger‐tapping task with the dominant hand. Excitability, inhibition (expressed as percent change scores from pre‐ to post‐training), motor task performance and bilateral transfer were assessed between groups. Investigation of hemispheric differences within each group was completed for measures that significantly differed between groups. There were no between‐group differences in task performance or bilateral transfer, with task performance improving post‐training irrespective of group for both hands (p < 0.05). Pre‐ to post‐inhibition change scores of the untrained EDC muscle increased (p = 0.034) in older compared with younger adults, indicating reduced inhibition in older adults. Inhibition change scores significantly differed between hemispheres for the young group only (p = 0.037). Only the younger group presented with hemispheric lateralisation, providing some support for the Hemispheric Asymmetry Reduction in OLDer adults (HAROLD) hypothesis. Whether this reduction is evidence of de‐differentiation or compensation will need to be confirmed with additional measures.


  • Acute effects of combined Bacopa, American ginseng and whole coffee fruit on working memory and cerebral haemodynamic response of the prefrontal cortex: a double-blind, placebo-controlled study

    by Talitha Best, Chantelle Clarke, Nathan Nuzum, Wei-Peng Teo

    Objective: This study assessed whether a multi-ingredient herbal supplement containing Bacopa monniera (BM), Panax quinquefolius ginseng (PQ) and whole coffee fruit extract (WCFE) could enhance cognitive performance and cerebral-cortical activation during tasks of working memory and attention. Method: In a randomised, double-blind, placebo-controlled, between-group study, 40 healthy adults between 18–60 years (M = 34.46 SD = 12.95) completed tasks of working memory and attention at baseline and 45 min post active or placebo supplement consumption. During the cognitive testing, changes in hemodynamic response in the prefrontal cortex (PFC) were continuously measured using functional near-infrared spectroscopy (fNIRS). Results: Working memory task performance on the N-back task was significantly improved following active supplement consumption compared to placebo in terms of accuracy (p < .01) and response time (p < .05). Improved performance was associated with a reduction of PFC activation (p < .001) related to effortful mental demand, reflecting increased neural efficiency concomitant with improved cognitive performance. The effects were independent of background demographics variables and changes in blood glucose response and mood. Discussion: This is the first report of acute effects on cognitive performance in healthy adults following intake of a combined, multi-ingredient herbal supplement with concomitant changes in cerebral haemodynamic response. The potential synergistic effects of polyphenolic compounds on neurocognitive function and fNIRS use in nutritional intervention studies, poses a significant increase in the capacity to understand the effects of dietary compounds on the brain.


  • High intensity aerobic exercise does not prime the brain for anodal transcranial direct current stimulation

    by Ashlee M. Hendy, Helen Macpherson, Nathan D. Nuzum, Paul A. Della Gatta, Sarah E. Alexander, Kate E. Hoy, Peter G. Enticott, Wei-Peng Teo


  • Open Access

    Activity in the right frontal cortex is dependent on inhibitory-demand: a functional near infrared spectroscopy study

    by Jason He, Genevieve Steiner, Jack Fogarty, Nathan Nuzum, Miki Finch, Saskia Kruitwagen, Nathan Sage, Wei-Peng Teo

    The ability to supress inappropriate or unwanted behaviour, known as inhibition, can be indexed using a variety of task paradigms, one of the more common being the Go/No-go task. Studies in which popular neuroimaging methods such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) were used to measure neural activity during participant performance of the Go/No-go task have often identified ‘inhibitory-related’ activity in the right prefrontal cortex (PFC). While studies using functional near-infrared spectroscopy (fNIRS) have also identified changes in activity in the right PFC, the variants of the Go/No-go tasks previously employed in those studies have made it difficult to be confident that those changes measured using fNIRS were specifically related to inhibition. To determine whether the change in activity identified in the right PFC with fNIRS by previous studies using the Go/No-go task were indeed related to inhibition, we had participants complete three conditions of the Go/No-go task, each with varying levels of inhibitory demand (manipulated by the relative frequency of Go to No-go trials). We found that as Go-trial frequency increased, participants performed faster on Go-trials and less accurately on No-go trials. More importantly, as inhibitory-demand increased, activity in the right but not left PFC increased. When taken together, these findings are in support of the idea that the changes measured in the right PFC in earlier studies using fNIRS during the Go/No-go task were indeed related to inhibition.